Hennion & Walsh Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-132,137
| Closed | -$1.27M | – | 771 |
|
|
2022
Q3 | $1.27M | Sell |
132,137
-7,465
| -5% | -$71.7K | 0.08% | 274 |
|
|
2022
Q2 | $1.01M | Sell |
139,602
-6,487
| -4% | -$47K | 0.06% | 308 |
|
|
2022
Q1 | $1.89M | Sell |
146,089
-5,258
| -3% | -$67.9K | 0.1% | 226 |
|
|
2021
Q4 | $2.42M | Sell |
151,347
-13,838
| -8% | -$221K | 0.12% | 214 |
|
|
2021
Q3 | $2.66M | Sell |
165,185
-3,641
| -2% | -$58.5K | 0.14% | 206 |
|
|
2021
Q2 | $2.34M | Buy |
168,826
+23,307
| +16% | +$322K | 0.12% | 220 |
|
|
2021
Q1 | $2.13M | Buy |
+145,519
| New | +$2.13M | 0.13% | 219 |
|